Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

AGM Statement

29 Sep 2010 07:00

RNS Number : 4602T
Imaginatik PLC
29 September 2010
Β 

ο»Ώ

Β 29 September 2010

Imaginatik plc

("Imaginatik" or the "Company")

Β 

AGM Statement

Contract Win and Management Appointments

Β 

At the Company's Annual General Meeting to be held later today, Matthew Cooper, Executive Chairman of Imaginatik plc (AIM: IMTK.L), a leading provider of idea management software and innovation consultancy, will make the following statement:

Β 

"We continue to make steady progress towards achieving our strategic goals. A new management team is now largely in place and has been further strengthened by the two recent appointments referred to below.

Β 

"As stated in the announcement dated 18 August 2010, we believe that it will take time to rebuild the Company's sales pipeline. However, the recently announced contract wins and a further win with the U.S. Government announced today are evidence of a growing momentum.

Β 

"While the re-organisation of the business earlier this year will inevitably have an impact on results for the first half of the year, we expect to see a return to more normal levels of sales in the second half.

Β 

"The calibre of people joining our team and the high profile customers with whom we continue to work give us confidence in the future of Imaginatik."

Β 

The Company also announces today a contract win and two senior management team appointments.

Β 

Contract to supply innovation solutions to the United States Government, General Services Administration

Β 

Imaginatik has been selected as a strategic innovation solutions provider by QinetiQ North America, Inc. in support of the United States Government, General Services Administration (the "GSA"). QinetiQ North America, one of the world's leading defence technology and security companies, has issued Imaginatik a six month Subcontract Agreement worth over $400,000, with one six month option period, to assist in enabling Business Transformation and Collaboration at the GSA. Under this Agreement, Imaginatik will use its Idea Central Collaboration Platform to assist GSA in identifying innovation strategies to enhance business practices. It includes licenses for GSA's 15,000 associates, facilitation and programme management support, and various training initiatives to foster collaboration at GSA.

Β 

Senior Appointments

Β 

Imaginatik is also pleased to announce it has made two recent senior appointments to strengthen the Company's sales and product development capabilities. Neither appointment is a Board position.

Β 

Kevin Grygiel has been appointed Global Vice-President of Sales. Based in Boston, Kevin will lead the sales organisation, reporting to Luis Solis the Vice-President of Business Development. Kevin has more than 20 years in software sales, with the last eight years at SiteScape Inc. a collaboration and social media software business. This appointment affirms the Company's commitment to bringing in high calibre sales executives with relevant expertise capable of growing the business.

Β 

Robin Spencer, previously Senior Research Fellow, Idea Management & Innovation at Pfizer Inc., has joined Imaginatik as Director of Research. Rob will work within the Product Development team in building out all future product enhancements and will continue Imaginatik's tradition of leading edge empirical research within our field of innovation and collaborative problem solving.

Β 

For further information please contact:

Β 

Imaginatik plc

Tel: 020 7917 2975

Matthew Cooper, Chairman / Shawn Taylor, CFO

Arbuthnot Securities Limited

Tel: 020 7012 2000

Tom Griffiths

Threadneedle Communications

Tel: 020 7653 9850

Caroline Evans-Jones / Hilary Millar

Β 

Β 

About Imaginatik

Β 

Imaginatik provides Innovation and idea management solutions to companies such as The Chubb Group of Insurance Companies, Boeing, Pfizer, Xerox, Goodyear and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. This is Imaginatik's area of expertise.

Β 

Imaginatik provides customers with strategic consulting, the award-winning Idea Central technology solution and an experienced, results-oriented innovation consulting team.

Β 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and a World Economic Forum Technology Pioneer with offices in Boston, MA, and London. In 2009, Imaginatik was named as one of the 500 fastest growing technology companies in the EMEA region by Deloitte.

Β 

For more information visit www.imaginatik.com.

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
AGMDMGZLKRGGGZM
Date   Source Headline
27th Nov 20137:00 amRNSHalf Yearly Report
24th Oct 20137:00 amRNSContract Win
10th Oct 201310:01 amRNSHolding(s) in Company
2nd Oct 20137:00 amRNSIssue of Equity
1st Oct 201310:03 amRNSTransaction in Own Shares/Director's Dealing
23rd Sep 20137:00 amRNSContract Win with Shell
18th Sep 20132:03 pmRNSResult of AGM
27th Aug 20131:50 pmRNSNotice of AGM
24th Jul 20137:00 amRNSFinal Results
8th Jul 20137:00 amRNSContract Win
1st Jul 20137:00 amRNSChange of Adviser
21st Jun 20137:00 amRNSBoard Changes
13th Jun 20137:00 amRNSConsultancy Update
31st May 20137:00 amRNSTotal Voting Rights
16th May 20131:03 pmRNSHolding(s) in Company
16th May 20137:00 amRNSHolding(s) in Company
13th May 201312:16 pmRNSResult of General Meeting
26th Apr 20134:52 pmRNSPublication of Circular
26th Apr 20137:00 amRNSProposed Placing
16th Apr 201312:20 pmRNSCapital Market Strategy Update
7th Feb 20132:25 pmRNSTrading Update
10th Dec 20127:00 amRNSContract Wins
22nd Nov 20127:00 amRNSShare Options
21st Nov 20127:00 amRNSHalf Yearly Report
25th Oct 20127:00 amRNSTrading Update
2nd Oct 20127:00 amRNSLitigation Conclusion
14th Sep 20121:02 pmRNSResult of AGM
14th Sep 20127:00 amRNSAGM Statement
23rd Aug 20127:00 amRNSNotice of AGM
4th Jul 201212:04 pmRNSHolding(s) in Company
2nd Jul 20122:22 pmRNSHolding(s) in Company
29th Jun 20123:30 pmRNSHolding(s) in Company
29th Jun 201212:12 pmRNSHolding(s) in Company
28th Jun 20121:36 pmRNSHolding(s) in Company
27th Jun 201211:20 amRNSResult of General Meeting
20th Jun 20121:41 pmRNSDirectorate Change
11th Jun 20128:30 amRNSDirector/PDMR Shareholding
11th Jun 20128:00 amRNSProposed Placing
11th Jun 20128:00 amRNSFinal Results
17th Apr 20127:00 amRNSTrading Update
17th Apr 20127:00 amRNSContract Wins
29th Feb 20127:00 amRNSContract with US Healthcare Services Provider
21st Feb 20121:45 pmRNSHolding(s) in Company
20th Feb 201212:54 pmRNSHolding(s) in Company
15th Feb 201212:16 pmRNSHolding(s) in Company
15th Feb 20127:00 amRNSShare Option Schemes
8th Feb 20127:00 amRNSIssue of Equity
3rd Feb 201211:39 amRNSHolding(s) in Company
2nd Feb 201210:49 amRNSHolding(s) in Company
30th Jan 20127:00 amRNSSenior Management Appointments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.